| 2000 |
Human NUPR1 (p8) has properties of HMG-I/Y proteins, is monomeric and partially unfolded in solution, binds DNA weakly, and is a substrate for protein kinase A (PKA); phosphorylation by PKA increases secondary structure content and dramatically enhances DNA binding. |
Circular dichroism, FTIR, NMR spectroscopy, electrophoretic gel shift assay, in vitro PKA phosphorylation assay |
The Journal of biological chemistry |
High |
11056169
|
| 2006 |
NUPR1 (p8) forms a complex with the antiapoptotic protein prothymosin alpha (ProTalpha); the interaction induces conformational changes in both proteins and both must be co-expressed for the antiapoptotic response to staurosporine in HeLa cells. |
Yeast two-hybrid, fluorescence spectroscopy, circular dichroism, NMR spectroscopy, siRNA knockdown/overexpression, caspase 3/7 and 9 activity assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16478804
|
| 2008 |
NUPR1 forms a complex with p53 and p300, binds the p21 promoter, and transcriptionally upregulates p21 expression; it also promotes phosphorylation of Rb and upregulation of Bcl-xL, conferring resistance to doxorubicin and Taxol. |
Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), luciferase reporter assay, siRNA knockdown, Western blot |
Current cancer drug targets |
Medium |
18690848
|
| 2002 |
p8-deficient mouse embryonic fibroblasts grow more rapidly due to elevated Cdk2/Cdk4 activity and decreased p27 levels, and are more resistant to adriamycin-induced apoptosis; p8 overexpression increases p53 protein level and trans-activation capacity, and p53 negatively trans-activates p8, forming an autoregulatory loop. |
p8-/- mouse embryonic fibroblasts, kinase activity assay, Western blot, reporter assay, apoptosis assay |
Oncogene |
High |
11896600
|
| 2006 |
p8 is required for endothelin- and alpha-adrenergic agonist-induced cardiomyocyte hypertrophy and for TNF-stimulated induction of MMP9 and MMP13 in cardiac fibroblasts; p8 associates with chromatin at c-Jun-containing sites on the ANF, MMP9 and MMP13 promoters in a stimulus-dependent manner. |
Chromatin immunoprecipitation (ChIP), RNAi knockdown, gene expression analysis, primary cardiomyocyte and fibroblast assays |
Molecular and cellular biology |
High |
17116693
|
| 2005 |
p8 interacts with Jab1; this interaction is required for Jab1-induced translocation of p27 from nucleus to cytoplasm and its subsequent degradation; knockdown of p8 strongly inhibits Jab1 activity. |
Yeast two-hybrid, His6-pulldown, co-immunoprecipitation, co-localization, siRNA knockdown, p27 localization assay |
Biochemical and biophysical research communications |
High |
16300740
|
| 2009 |
p8 (NUPR1) acts as a corepressor of FoxO3 transcription factor; p8 knockdown increases FoxO3 nuclear localization, increases FoxO3 association with the Bnip3 promoter, and elevates Bnip3 levels, leading to increased autophagy and apoptosis. p8-/- mice show elevated cardiac autophagy, higher Bnip3, and impaired cardiac function. |
RNAi in cardiomyocytes/H9C2/U2OS cells, FoxO3 transcriptional activity assay, ChIP, p8-/- mouse cardiac phenotyping, pharmacological autophagy inhibitors, Atg5 siRNA |
Molecular biology of the cell |
High |
20181828
|
| 2009 |
p8 (NUPR1) binds to histone acetyltransferase p300 and co-occupies the myogenin promoter together with p300, MyoD, and p68 (Ddx5); p8 knockdown compromises chromatin association of all four proteins, impairs p300-dependent events (Myc expression, histone acetylation, MyoD acetylation) and severely impairs myogenic differentiation. |
Co-immunoprecipitation, ChIP, siRNA knockdown, differentiation assays in C2C12 myoblasts |
Journal of cell science |
High |
19723804
|
| 2006 |
Com-1 (NUPR1) interacts with estrogen receptor-beta (ER-beta) in breast cancer cells as shown by co-immunoprecipitation; ER-beta and Com-1 share identical nuclear localization; 17-beta-estradiol stimulation reduces nuclear Com-1 staining in a ubiquitin-proteasome pathway-dependent manner. |
Co-immunoprecipitation, immunocytochemistry, ribozyme transgene knockdown, ubiquitin/proteasome inhibitor treatment |
Biochemical and biophysical research communications |
Medium |
15781258
|
| 2006 |
p8 (NUPR1) shows cell growth-dependent subcellular localization: nuclear in actively dividing sub-confluent cells, nucleo-cytoplasmic in G0/G1-arrested cells. A conserved bipartite NLS (including Lys65, 69, 76, 77) is required for nuclear import. Nuclear localization is energy-dependent and is regulated by acetylation (trichostatin A causes cytoplasmic accumulation). Nuclear export does not involve CRM1. |
Immunocytochemistry, GFP-fusion protein localization, NLS mutagenesis, pharmacological inhibitors (sodium azide/2-DG, leptomycin B, trichostatin A), live-cell imaging |
Journal of cellular biochemistry |
High |
16294328
|
| 2017 |
NUPR1 binds to the C-terminal region of Polycomb protein RING1B with ~10 µM affinity; the binding region on NUPR1 is a hydrophobic patch at the '30s region' (around Ala33); Ala33Gln and Thr68Gln mutations reduce this binding. The interaction is inhibited by trifluoperazine. Interaction was confirmed in cellulo by protein ligation assay. |
NMR, site-directed mutagenesis, isothermal titration calorimetry, molecular docking, protein ligation assay in cellulo |
Proceedings of the National Academy of Sciences of the United States of America |
High |
28720707
|
| 2019 |
ZZW-115 (a trifluoperazine-derived compound) binds NUPR1 through the region around Thr68, which is located in the NLS region; ZZW-115 inhibits nuclear translocation of NUPR1 by competing with importins, induces tumor regression in xenografted mice, and causes cell death primarily by necroptosis. |
Biophysical binding assays (ITC, fluorescence), molecular modeling, cell viability assays, mouse xenograft model, nuclear translocation assay |
The Journal of clinical investigation |
High |
30920390
|
| 2019 |
NUPR1 binds to several importin proteins (establishing its nuclear translocation mechanism); ZZW-115 competes with importins for binding to the NLS region of NUPR1, inhibiting nuclear translocation; NUPR1 directly stimulates the SUMOylation machinery in a cell-free system, and ZZW-115 reduces SUMOylation of DDR proteins, sensitizing cancer cells to genotoxic agents. |
Interactome/mass spectrometry proteomics, nuclear translocation assay, cell-free SUMOylation assay with recombinant NUPR1, co-immunoprecipitation, genotoxicity assays |
JCI insight |
High |
32780723
|
| 2020 |
Phosphorylation of Thr68 in the NLS of NUPR1 hampers its binding to importin α3 (Impα3); the phosphorylated peptide adopts a turn-like conformation (confirmed by 2D NMR NOE), while the unphosphorylated peptide is random coil; removal of Lys65 or Lys69 also reduces binding, indicating importance of positive charges. |
NMR spectroscopy (2D 1H-NMR, NOE), isothermal titration calorimetry, molecular docking, fluorescence spectroscopy, peptide phospho-mimetic mutagenesis |
Biomolecules |
High |
32933064
|
| 2021 |
NUPR1 drives ferroptosis resistance by transcriptionally activating LCN2 expression, which reduces intracellular iron accumulation and subsequent oxidative damage; LCN2 depletion mimics NUPR1 deficiency for ferroptosis induction, and re-expression of LCN2 restores resistance in NUPR1-deficient cells. |
NanoString technology, shRNA knockdown, LCN2 overexpression rescue, pancreas-specific Lcn2 conditional knockout mice, erastin treatment, pancreatitis mouse models |
Nature communications |
High |
33510144
|
| 2022 |
NUPR1 binds PARP1 in the nucleus and inhibits PARP1 activity in vitro; NUPR1 inactivation (by ZZW-115 or genetic knockout) leads to hyperPARylation, mitochondrial catastrophe (membrane potential loss, superoxide production, ROS increase, Ca2+ elevation), and cell death through a non-canonical Parthanatos (AIF does not translocate from mitochondria); this cell death is rescued by the PARP inhibitor olaparib or NAD+ precursor NMN. |
Co-immunoprecipitation (NUPR1–PARP1), in vitro PARP1 activity assay with recombinant NUPR1, NUPR1 mutants (Ala33, Thr68), ZZW-115 treatment, NAD+/NADH measurement, mitochondrial membrane potential, superoxide/ROS assays, olaparib/PARG inhibitor rescue |
Communications biology |
High |
35869257
|
| 2018 |
Inactivation of NUPR1 in pancreatic cancer cells causes mitochondrial failure (loss of membrane potential, ROS increase, decreased OXPHOS/ATP), relocation of mitochondria near ER, and ER-stress-coupled necrotic cell death that is reversed by necrostatin-1 (necroptosis inhibitor) but not by Z-VAD-FMK (caspase inhibitor). NUPR1 expression protects acinar cells from necrosis in vivo. |
NUPR1 shRNA/siRNA knockdown, transcriptomic analysis, mitochondrial membrane potential assay, ROS assay, ATP measurement, necrostatin-1/Z-VAD-FMK rescue, thapsigargin/brefeldin A/tunicamycin ER stress induction, acute pancreatitis mouse model |
Scientific reports |
High |
30451898
|
| 2015 |
Nupr1 acts as a gene modifier of Kras(G12D)-induced senescence by regulating Dnmt1 expression and genome-wide DNA methylation levels; Nupr1 deficiency in Kras(G12D) mice increases β-galactosidase-positive (senescent) cells and activates the FoxO3a-Skp2-p27Kip1-pRb-E2F senescence pathway in vivo and in vitro. |
Nupr1-/- × Kras(G12D) mouse genetics, β-galactosidase staining, DNA methylation analysis, RNAi in human pancreatic cancer cells, Dnmt1 expression analysis, FoxO3a/Skp2/p27 pathway analysis |
Scientific reports |
High |
26617245
|
| 2014 |
Nupr1 cooperates with oncogenic Kras(G12D) to bypass senescence and promote PanIN formation; genetic inactivation of Nupr1 impairs Kras-induced PanIN in mice, increasing senescent (β-galactosidase-positive) cells and activating the FoxO3a-Skp2-p27Kip1-pRb-E2F pathway. |
Pdx1-cre;LSL-KrasG12D;Nupr1-/- mouse model, β-galactosidase staining, gene expression profiling, RNAi in pancreatic cancer cells, pathway analysis |
Cell death and differentiation |
High |
24902898
|
| 2012 |
NUPR1 confers chemoresistance in p53-deficient inflammatory breast cancer cells by causing Akt-mediated phosphorylation of p21 and its cytoplasmic re-localization, as well as activation of anti-apoptotic Bcl-xL; this defines a NUPR1-PI3K/Akt-phospho-p21 axis. |
NUPR1 overexpression/knockdown, Akt inhibitor treatment, Western blot for phospho-p21 and cytoplasmic/nuclear fractionation, Bcl-xL measurement, chemoresistance assays |
FEBS letters |
Medium |
22858377
|
| 2002 |
p8 expression is required for tumor formation: transformed p8-/- MEFs cannot form colonies in soft agar or tumors in nude mice, while restoration of p8 expression in p8-/- MEFs restores tumor-forming ability. |
p8-/- MEF transformation with rasV12/E1A, soft agar colony assay, subcutaneous and intraperitoneal tumor formation in nude mice, p8 rescue by re-expression |
EMBO reports |
High |
11818333
|
| 2015 |
NUPR1 knockdown suppresses liver cancer cell invasion in a Ca2+-signaling-dependent manner; granulin was identified as a key downstream transcriptional effector of NUPR1 via promoter binding assay; the NUPR1-granulin pathway is associated with mitochondrial defect-derived glycolytic activation. |
NUPR1 knockdown, invasion assay with Ca2+ signaling inhibitors, promoter binding (ChIP-like) assay, gene expression profiling |
Hepatology |
Medium |
26173068
|
| 2022 |
NUPR1 interacts with aryl hydrocarbon receptor (AhR) and promotes AhR degradation via the autophagy-lysosome pathway and decreased nuclear AhR translocation, thereby reducing CYP enzyme transcription, lowering ROS generation after ionizing radiation, and conferring radioresistance in hepatocellular carcinoma. |
Co-immunoprecipitation (NUPR1-AhR), RNA sequencing, ROS/lipid peroxidation assays, colony formation assay, xenograft tumor model, AhR activator rescue |
BMC medicine |
Medium |
36258210
|
| 2022 |
NUPR1 promotes cancer cell proliferation and metastasis by directly increasing TFE3 transcriptional activity, which maintains autophagic flux and lysosomal function; NUPR1 knockdown suppresses TFE3-dependent autophagy. |
NUPR1 stable knockdown, label-free quantitative proteomics, tandem mass tag proteomics, TFE3 activity assay, autophagy flux assay, in vitro and in vivo tumor models |
Signal transduction and targeted therapy |
Medium |
35462576
|
| 2016 |
NUPR1 silencing in HCC cells influences expression of RELB and IER3 genes; NUPR1 regulates RUNX2 expression; these together define a NUPR1/RELB/IER3/RUNX2 pathway regulating NF-κB and ERK signaling in HCC. |
Stable NUPR1 knockdown, gene expression profiling, network analysis, RUNX2/RELB/IER3 siRNA, cell viability/migration assays, sorafenib sensitivity assays |
Cell death & disease |
Medium |
27336713
|
| 2016 |
NUPR1 is downregulated in highly malignant tumor-repopulating cells (TRCs) grown in soft fibrin matrices; this downregulation is mediated by YAP nuclear translocation (controlled by Cdc42-mediated F-actin and Lats1); Nupr1 negatively regulates Nestin and Tert expression and suppresses TRC growth. |
Soft fibrin matrix TRC culture, YAP ChIP at Nupr1 promoter, Nupr1 siRNA/overexpression, Cdc42/Lats1 pathway inhibition, in vivo tumor formation in immune-competent mice |
Oncogenesis |
Medium |
27089143
|
| 2011 |
Amino acid starvation induces p8 expression via the GCN2/ATF4 pathway; an Amino Acid Response Element (AARE) in the p8 promoter mediates this regulation; evidence provided in vitro and in vivo. |
p8 promoter AARE mutagenesis, reporter assay, ATF4 knockdown, GCN2-/- mouse studies, amino acid deprivation experiments |
Biochemical and biophysical research communications |
Medium |
21867687
|
| 2017 |
Nupr1 mediates METH-induced neuronal apoptosis and autophagy through the CHOP-Trib3 endoplasmic reticulum stress signaling pathway; silencing Nupr1 reduces METH-induced apoptosis and autophagy both in vitro (neurons, PC12 cells) and in vivo (rat striatum via lentivirus-mediated shRNA). |
shRNA/siRNA knockdown of Nupr1, CHOP, Trib3 in primary neurons and PC12 cells; lentiviral striatum injection in rats; Western blot for ER stress, apoptosis, autophagy markers |
Frontiers in molecular neuroscience |
Medium |
28694771
|
| 2021 |
Nupr1 mediates TGF-β-induced myofibroblast activation and EMT via the Smad3 signaling pathway; Nupr1-/- mice are protected from UUO-induced renal fibrosis; the NUPR1 inhibitor trifluoperazine (TFP) alleviates renal fibrosis in vivo. |
Nupr1-/- mouse UUO model, TGF-β treatment of fibroblasts/epithelial cells, α-SMA/collagen expression, Smad3 phosphorylation analysis, TFP pharmacological inhibition |
FASEB journal |
High |
33617091
|
| 2022 |
Nupr1 regulates HSC quiescence by inhibiting p53 expression; Nupr1 deletion activates quiescent HSCs and confers competitive engraftment advantage; restoration of p53 in Nupr1-/- HSCs offsets the engraftment advantage. |
Nupr1-/- mouse model, competitive transplantation assay, serial transplantation, p53 rescue experiment, in vitro expansion protocol |
Haematologica |
Medium |
33299232
|
| 2013 |
Nupr1 suppresses β-cell proliferation by inhibiting Ccna2 and Tcf19 promoter activities; Nupr1-/- mice have increased β-cell mass due to enhanced islet cell proliferation and are protected from HFD-induced glucose intolerance. |
Nupr1-/- mouse model, BrdU incorporation (β-cell proliferation), luciferase reporter for Ccna2 and Tcf19 promoters, gene arrays, HFD challenge |
Diabetologia |
High |
23900510
|
| 2025 |
Tumor-derived lactate upregulates NUPR1 expression in tumor-associated macrophages via histone lactylation; NUPR1 then inhibits ERK and JNK signaling, promotes M2 macrophage polarization and PD-L1/SIRPA expression, leading to CD8+ T cell exhaustion and immune suppression. |
scRNA-seq analysis, functional in vitro and in vivo assays, histone lactylation assay, ERK/JNK pathway analysis, pharmacological NUPR1 inhibition, PD-1 blockade combination experiments |
Advanced science |
Medium |
40305758
|
| 2023 |
WTAP promotes NUPR1 expression via m6A modification in an eIF3A-mediated manner (m6A-EIF3A mechanism), which stabilizes NUPR1 mRNA; NUPR1 in turn positively regulates LCN2 transcription to suppress ferroptosis in triple-negative breast cancer cells. |
m6A dot blot assay, RNA immunoprecipitation (RIP), RNA degradation assay, WTAP/NUPR1/LCN2 siRNA, iron/GSH measurements |
Biochemical genetics |
Medium |
37477758
|
| 2024 |
NUPR1 promotes FTH1 transcription in HCC cells, enhancing iron storage and conferring resistance to ferroptosis; this is driven upstream by circPIAS1 sponging miR-455-3p to increase NUPR1 levels. ChIP confirmed NUPR1 binding to the FTH1 promoter. |
RNA immunoprecipitation, luciferase reporter, RNA pulldown, FISH, ChIP (NUPR1 at FTH1 promoter), NUPR1 knockdown/overexpression, ZZW-115 treatment, xenograft mouse model |
Molecular cancer |
High |
38802795
|